Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-12 Sale |
2021-08-13 6:35 pm |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
45,000 | $107.01 | $4,815,377 | 1,172,002 (Indirect Direct) |
View |
| 2021-07-30 Purchase |
2021-08-03 9:12 pm |
DA32 Life Science Tech Acquisition Corp. | DALS | CRANDELL KEITH Director 10% Owner |
1,600,000 | $10 | $16,000,000 | 2,250,000 (Indirect) |
View |
| 2020-12-22 Purchase |
2020-12-22 8:17 pm |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
300,000 | $20 | $6,000,000 | 5,725,045 (Indirect) |
View |
| 2020-12-07 Sale |
2020-12-09 5:11 pm |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
75,000 | $103.4 | $7,755,000 | 2,643,838 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-08 Option Award |
2022-02-10 7:32 pm |
N/A N/A |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
3,491 | $0 | 80,024 (Direct) |
View |
| 2021-11-16 Other |
2022-01-05 4:06 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
619,520 | $0 | 741,779 (Indirect) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:06 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
307 | $42.41 | 741,779 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:06 pm |
2022-12-31 2032-01-03 |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
6,670 | $0 | 741,779 (Direct) |
View |
| 2021-12-20 Other |
2021-12-22 5:59 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,811,207 | $0 | 12,527,079 (Indirect) |
View |
| 2021-11-29 Other |
2021-12-01 6:30 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
517,485 | $0 | 12,205,620 (Indirect) |
View |
| 2021-11-22 Other |
2021-11-24 5:58 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
517,485 | $0 | 12,483,411 (Indirect) |
View |
| 2021-08-10 Other |
2021-10-05 4:02 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
639,906 | $0 | 969,610 (Indirect) |
View |
| 2021-10-01 Option Award |
2021-10-05 4:02 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
254 | $51.18 | 969,610 (Direct) |
View |
| 2021-02-11 Other |
2021-08-13 6:35 pm |
N/A N/A |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
1,051,881 | $0 | 1,172,002 (Indirect) |
View |
| 2021-07-30 Option Award |
2021-08-03 9:12 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | CRANDELL KEITH Director 10% Owner |
650,000 | $10 | 2,250,000 (Indirect) |
View |
Ownership |
2021-07-27 9:51 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | CRANDELL KEITH Director 10% Owner |
0 | $0 | 5,196,250 (Direct) |
View |
| 2021-07-20 Conversion |
2021-07-20 8:53 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
18,794,443 | $0 | 5,527,777 (Indirect) |
View |
Ownership |
2021-07-15 9:06 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 11,055,554 (Indirect) |
View |
| 2021-05-13 Other |
2021-07-06 5:17 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director |
1,083,710 | $0 | 1,634,632 (Indirect) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:17 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director |
218 | $59.48 | 1,634,632 (Direct) |
View |
| 2021-03-09 Other(A) |
2021-07-06 5:17 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director |
877,287 | $0 | 1,803,061 (Indirect) |
View |
| 2021-04-01 Option Award(A) |
2021-07-06 5:17 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director |
211 | $61.45 | 1,803,061 (Direct) |
View |
| 2021-07-01 Other |
2021-07-06 4:47 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
4,033,412 | $0 | 16,277,129 (Indirect) |
View |
| 2021-06-30 Other |
2021-07-02 5:19 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner |
208,052 | $0 | 3,357,682 (Indirect) |
View |
| 2021-06-25 Other |
2021-06-29 5:22 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner |
416,104 | $0 | 3,961,048 (Indirect) |
View |
| 2021-06-22 Other |
2021-06-24 5:03 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,008,348 | $0 | 15,501,684 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:42 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
54,619,074 | $0 | 18,206,358 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 4:29 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
25,739,146 | $0 | 1,254,405 (Indirect) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:07 am |
N/A 2031-06-17 |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
3,834 | $0 | 3,834 (Direct) |
View |
Ownership |
2021-06-16 9:00 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
0 | $0 | 36,412,716 (Indirect) |
View |
Ownership |
2021-06-16 7:35 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 2,508,809 (Indirect) |
View |
| 2021-04-13 Other |
2021-04-15 5:18 pm |
N/A N/A |
Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner |
76,264 | $0 | 1,608,617 (Indirect) |
View |
| 2021-04-07 Other |
2021-04-09 5:07 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,008,360 | $0 | 16,064,106 (Indirect) |
View |
| 2021-04-01 Option Award |
2021-04-02 9:43 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
211 | $61.45 | 3,134,888 (Direct) |
View |
| 2021-03-31 Other |
2021-04-02 3:19 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
203,366 | $0 | 3,927,319 (Indirect) |
View |
| 2021-03-30 Other |
2021-04-01 5:24 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,008,350 | $0 | 16,626,496 (Indirect) |
View |
| 2021-03-18 Other |
2021-03-22 7:34 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
406,731 | $0 | 4,529,873 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 7:22 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
65,625,000 | $0 | 11,718,750 (Indirect) |
View |
| 2021-02-03 Option Award |
2021-02-05 8:30 pm |
N/A 2031-02-02 |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director 10% Owner |
1,459 | $0 | 1,100,501 (Direct) |
View |
Ownership |
2021-02-03 9:30 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 44,042,500 (Indirect) |
View |
| 2021-01-08 Other |
2021-01-12 4:44 pm |
N/A N/A |
Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner |
76,264 | $0 | 1,683,311 (Indirect) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:04 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
197 | $44.11 | 3,142,577 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:04 pm |
2021-12-31 2031-01-04 |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
10,170 | $0 | 3,142,577 (Direct) |
View |
| 2020-12-22 Conversion |
2020-12-22 8:17 pm |
N/A N/A |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
10,850,090 | $0 | 5,725,045 (Indirect) |
View |
| 2020-12-17 Option Award |
2020-12-21 7:01 pm |
N/A N/A |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
14,410 | $0 | 14,410 (Direct) |
View |
Ownership |
2020-12-17 8:08 pm |
N/A N/A |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
0 | $0 | 5,425,045 (Indirect) |
View |
| 2020-08-18 Other |
2020-12-09 5:11 pm |
N/A N/A |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
2,354,322 | $0 | 2,643,838 (Indirect) |
View |
| 2020-11-20 Other |
2020-11-24 8:59 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
831,322 | $0 | 2,058,051 (Indirect) |
View |
| 2020-11-12 Other |
2020-11-16 6:14 pm |
N/A N/A |
Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner |
76,264 | $0 | 1,758,005 (Indirect) |
View |